Dr. Raymond Deshaies Speak at 3rd Ubiquitin Research and Drug Discovery Conference Feb 25-26, 2013 in Las Vegas, NV
Summary
Dr. Deshaies is a leading figure in the Ubiquitin field, has published over 100 papers and is an inventor on nine U.S. patents, many related to his work on the UPS.In addition to being a co-founder of Cleave Biosciences, Dr. Deshaies was the academic co-founder of Proteolix, which was sold in October 2009 to Onyx in a deal valued at up to $851 million.Dr. Deshaies is a leading figure in the Ubiquitin field, has published over 100 papers and is an inventor on nine U.S. patents, many related to his work on the UPS.In addition to being a co-founder of Cleave Biosciences, Dr. Deshaies was the academic co-founder of Proteolix, which was sold in October 2009 to Onyx in a deal valued at up to $851 million.The 3rd Ubiquitin Research and Drug Discovery Conference will bring together a 50-50 mix of academic and industry experts from leading affiliations (such as Elan, Millenium, Genentech, Celgene, Novartis, Onyx, Amgen, Cal-Tech, Emory University, Harvard, University of Washington, UCLA, etc.) to cover many current and relevant aspects of the Ubiquitin Proteasome Sturcture, Ligases, Sumo and more.This conference is also part of the 2nd Novel Cancer Therapeutic Summit, which consists of this track and two others:4th Cancer Targets and Therapeutics2nd Oncology Partnering and Deal MakingFor more information, please visit www.gtcbio.com Contact Information GTCbio David Stoops 626-256-6405 http://www.gtcbio.com 434 W. Foothill Blvd.